Cocrystal Pharma (COCP) Earnings Date, Estimates & Call Transcripts $1.69 +0.02 (+1.20%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$1.62 -0.07 (-4.14%) As of 07/17/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Cocrystal Pharma Earnings Summary Cocrystal Pharma issued Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.23, which topped analysts' consensus estimates of -$0.52 by $0.29. With a trailing EPS of -$1.57, Cocrystal Pharma's earnings are expected to decrease next year, from ($1.85) to ($2.16) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportCOCP Upcoming EarningsCocrystal Pharma's next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 15) -$0.52 Actual EPS (May. 15) -$0.23 Beat By $0.29 Get Cocrystal Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cocrystal Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCOCP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Cocrystal Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.60-$0.41-$0.52Q2 20253-$0.45-$0.20-$0.36Q3 20253-$0.45-$0.21-$0.32Q4 20253-$0.36-$0.21-$0.28 Cocrystal Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/15/2025Q1 2025-$0.52-$0.23+$0.29-$0.23--3/27/2025Q4 2024-$0.55-$0.32+$0.23-$0.32--8/14/2024--$0.51-$0.53 -$0.02-$0.53--5/13/2024Q1 2024-$0.54-$0.39+$0.15-$0.39--3/28/2024Q4 2023-$0.57-$0.44+$0.13-$0.44--11/13/2023Q3 2023-$0.47-$0.41+$0.06-$0.41--8/14/2023Q2 2023-$0.53-$0.50+$0.03-$0.50-- Cocrystal Pharma Earnings - Frequently Asked Questions When is Cocrystal Pharma's earnings date? Cocrystal Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on COCP's earnings history. Did Cocrystal Pharma beat their earnings estimates last quarter? In the previous quarter, Cocrystal Pharma (NASDAQ:COCP) reported ($0.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.52) by $0.29. Learn more on analysts' earnings estimate vs. COCP's actual earnings. How much profit does Cocrystal Pharma generate each year? Cocrystal Pharma (NASDAQ:COCP) has a recorded net income of -$17.50 million. COCP has generated -$1.57 earnings per share over the last four quarters. What is Cocrystal Pharma's EPS forecast for next year? Cocrystal Pharma's earnings are expected to decrease from ($1.85) per share to ($2.16) per share in the next year. More Earnings Resources from MarketBeat Related Companies GLPG Earnings Date INDV Earnings Date MEIP Earnings Date NTHI Earnings Date NEXI Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Citigroup Earnings Could Signal What’s Next for Markets3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting Cycle This page (NASDAQ:COCP) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cocrystal Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cocrystal Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
